Lecturer @UCL @School_Pharmacy | CStat, FHEA, FRSPH | #RxEpi | #ADHD | Exploring the world with data | Prenatal, Children & Mental health | Views are my own
London, England
Joined December 2013
- Tweets284
- Following373
- Followers254
- Likes725
Pinned Tweet
Honored with the Kramer-Pollnow Prize by @eunethydis! A heartfelt thank you to the organisation and to the brilliant minds in the field who inspire me every day. Grateful for this incredible recognition.
#KramerPollnowPrize #ADHD – at Montpellier, France
Kenneth Man retweeted
📰 Very happy to share that my first paper is now published in The Lancet Healthy Longevity.
In this target trial emulation study, we looked at whether stopping long-term antipsychotic treatment is safe for older adults living with dementia.
🔗 thelancet.com/journals/lanhl…
Kenneth Man retweeted
Our study using data from the UK CPRD Aurum published in @CIDJournal shows that metformin use within 90 days of COVID-19 diagnosis reduces post-COVID risk in individuals with overweight/obesity.
📮Read more: doi.org/10.1093/cid/ciaf429
@ChengshengJ @LiWeiUCL @KennethKCMan
Kenneth Man retweeted
"Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan", has been published by our international team! Read ascpt.onlinelibrary.wiley.co…
Kenneth Man retweeted
Our multinational network cohort study shows that extensive multi-organ involvement of post-COVID-19 condition over the short-term period and the subside in risk for most complications over the medium- and long-term. journals.sagepub.com/doi/10.…
🌍 Exciting PhD studentship at UCL School of Pharmacy!
Join the GENESIS project, a global collaboration using real-world data to advance mental health & maternal-child health research.
#PhD #Epidemiology #RegulatoryScience
🔗 ucl.ac.uk/pharmacy/study/mph…
Kenneth Man retweeted
The fifth and final member of our OPERA 2025 shortlist, @wallis_lau, was lauded by judges for her research’s influence on prescribing recommendations, ensuring safer anticoagulant use. Read more here: pharmaceutical-journal.com/a…
The overall winner will be announced on 30 June 2025 🏆
Kenneth Man retweeted
Our latest multinational study on trends in survival after #Dementia diagnosis has just been published with @SpringerNature in @CommsMedicine
Read here: rdcu.be/eocfU
@Ian_HKU @ChuiCeline @KennethKCMan @Knappem @GloW_hk
Kenneth Man retweeted
The findings of this new study do not support a direct effect of gabapentinoid treatment on self-harm but underscore the necessity for close patient monitoring of self-harm throughout the gabapentinoid treatment journey
@KennethKCMan
bmj.com/content/389/bmj-2024…
Kenneth Man retweeted
Treatment with gabapentinoids isn't directly associated with an increased risk of self-harm, finds this study.
However, rates of self-harm were higher before and shortly after treatment, highlighting the need for close monitoring of patients @KennethKCMan
bmj.com/content/389/bmj-2024…
New in @bmj_latest:
Gabapentinoid treatment not directly linked to increased self-harm risk.
Risk is highest before and after treatment—not during.
Close monitoring needed across the full treatment journey.
Read more: bmj.com/content/389/bmj-2024…
Kenneth Man retweeted
🧠 #TIMESPAN is transforming #ADHD research. By uniting global data, we explore ADHD's impact on cardiometabolic conditions, capture treatment variations, and drive better outcomes worldwide. #ADHDResearch #GlobalHealth
➡ Full blog post: timespan.eu/healthcare-data-…
Kenneth Man retweeted
🚨 'Comparative cardiometabolic safety and effectiveness of aripiprazole in people with severe mental illness: A target trial emulation' published in @PLOSMedicine doi.org/10.1371/journal.pmed…
PhD Opportunity @UCL 🌍
Join our global collaboration with SKKU & partners, tackling key health challenges in mental health & maternal-child health using real-world data!
💡 Open to passionate candidates in epidemiology, stats, pharmacy & more!
@FindAPhD: findaphd.com/phds/projectdet…
Kenneth Man retweeted
🚨 'Prescribing of antipsychotics for people diagnosed with severe mental illness in UK primary care 2000–2019: 20-year investigation of who receives treatment, with which agents and at what doses' now published in @TheBJPsych doi.org/10.1192/bjp.2024.186
Kenneth Man retweeted
Metformin was associated with a lower rate of asthma attacks, with further reductions with the use of GLP-1RA. ja.ma/3UQckFp
A very nice study by @BoheeLEE4 and @chloebloom using multiple study designs (self-controlled case series & cohort analysis) showed consistent results: metformin lowered asthma attack risk by ~30%, with GLP-1RA adding 40%. A robust approach to observational data!
This Post is from an account that no longer exists. Learn more
Great study lead by @fredho42 looked into factors contributing to the association between deprivation and infant death. Targeting moderating factors may mitigate some the effects but will not stem the rise in infant mortality. #heathinequalities
sciencedirect.com/science/ar…
I was an ad-hoc reviewer in June 2023 and then was invited to be an ERC core member in Feb 2024.
Happy to take one step further as ERC chair for CPRD.
Our new @OHDSI study in Lancet Psychiatry found that the prescribing rates of anxiolytics during the COVID-19 pandemic were persistently elevated, underscore the importance of enhanced mental health support and regular review of psychotropic drug use in the post-pandemic era.
